Literature DB >> 7613268

Poor response to erythropoietin.

I C Macdougall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7613268      PMCID： PMC2549809          DOI： 10.1136/bmj.310.6992.1424

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  16 in total

1.  Occult infection and resistance of anaemia to rHuEpo therapy in renal failure.

Authors:  N Muirhead; A B Hodsman
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

Review 2.  Erythropoiesis and inflammation.

Authors:  G Birgegård
Journal:  Contrib Nephrol       Date:  1989       Impact factor: 1.580

3.  Effect of aluminum overload on the bone marrow response to recombinant human erythropoietin.

Authors:  P Grützmacher; B Ehmer; D Messinger; K D Kulbe; P Scigalla
Journal:  Contrib Nephrol       Date:  1989       Impact factor: 1.580

4.  Detection of functional iron deficiency during erythropoietin treatment: a new approach.

Authors:  I C Macdougall; I Cavill; B Hulme; B Bain; E McGregor; P McKay; E Sanders; G A Coles; J D Williams
Journal:  BMJ       Date:  1992-01-25

5.  Use of recombinant erythropoietin in thalassemic patients on dialysis.

Authors:  K N Lai; K C Wong; P K Li; S F Lui
Journal:  Am J Kidney Dis       Date:  1992-03       Impact factor: 8.860

6.  Iron status in patients receiving erythropoietin for dialysis-associated anemia.

Authors:  D B Van Wyck; J C Stivelman; J Ruiz; L F Kirlin; M A Katz; D A Ogden
Journal:  Kidney Int       Date:  1989-02       Impact factor: 10.612

7.  Serum transferrin receptor: a quantitative measure of tissue iron deficiency.

Authors:  B S Skikne; C H Flowers; J D Cook
Journal:  Blood       Date:  1990-05-01       Impact factor: 22.113

8.  Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle-cell anaemia and renal failure.

Authors:  C R Tomson; M E Edmunds; K Chambers; S Bricknell; J Feehally; J Walls
Journal:  Nephrol Dial Transplant       Date:  1992       Impact factor: 5.992

9.  Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.

Authors:  K Kühn; B Nonnast-Daniel; P Grützmacher; J Grüner; W Pfåffl; C A Baldamus; P Scigalla
Journal:  Contrib Nephrol       Date:  1988       Impact factor: 1.580

10.  USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients.

Authors:  J W Eschbach; M R Downing; J C Egrie; J K Browne; J W Adamson
Journal:  Contrib Nephrol       Date:  1989       Impact factor: 1.580
View more
  4 in total

Review 1.  A review of quality of life in chronic renal failure.

Authors:  D S Parsons; D C Harris
Journal:  Pharmacoeconomics       Date:  1997-08       Impact factor: 4.981

2.  Iron therapy in the pediatric hemodialysis population.

Authors:  Bradley A Warady; Annamaria Kausz; Gary Lerner; Eileen D Brewer; Vimal Chadha; Carlo Brugnara; Naomi V Dahl; Sandra L Watkins
Journal:  Pediatr Nephrol       Date:  2004-04-03       Impact factor: 3.714

3.  Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis.

Authors:  Sarka Davidkova; Timothy D Prestidge; Peter W Reed; Tonya Kara; William Wong; Chanel Prestidge
Journal:  Pediatr Nephrol       Date:  2015-12-14       Impact factor: 3.714

4.  Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states.

Authors:  C Brugnara; B Schiller; J Moran
Journal:  Clin Lab Haematol       Date:  2006-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.